Clinical studies have explored the use of FMT as a potential treatment for obesity, with one study showing enhanced insulin sensitivity and decreased body weight in obese individuals with metabolic syndrome transplanted from lean donors [107]. The gene discussed is INS; the disease is obesity due to melanocortin 4 receptor deficiency.